Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

Related Articles by Review for PubMed (Select 16807300)

1.

Mitoenergetic failure in Alzheimer disease.

Parihar MS, Brewer GJ.

Am J Physiol Cell Physiol. 2007 Jan;292(1):C8-23. Epub 2006 Jun 28. Review.

2.

Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.

Aliev G, Palacios HH, Walrafen B, Lipsitt AE, Obrenovich ME, Morales L.

Int J Biochem Cell Biol. 2009 Oct;41(10):1989-2004. doi: 10.1016/j.biocel.2009.03.015. Epub 2009 Apr 5. Review.

PMID:
19703659
3.

Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.

Chen X, Yan SD.

IUBMB Life. 2006 Dec;58(12):686-94. Review.

PMID:
17424907
4.

Pathophysiology of neuronal energy crisis in Alzheimer's disease.

de la Torre JC.

Neurodegener Dis. 2008;5(3-4):126-32. doi: 10.1159/000113681. Epub 2008 Mar 6. Review.

PMID:
18322369
5.
6.

Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.

Aliev G, Smith MA, Obrenovich ME, de la Torre JC, Perry G.

Neurotox Res. 2003;5(7):491-504. Review.

PMID:
14715433
7.

Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.

Moreira PI, Santos MS, Seiça R, Oliveira CR.

J Neurol Sci. 2007 Jun 15;257(1-2):206-14. Epub 2007 Feb 20. Review.

PMID:
17316694
8.

Aging of the brain, entropy, and Alzheimer disease.

Drachman DA.

Neurology. 2006 Oct 24;67(8):1340-52. Review.

PMID:
17060558
9.

Mitochondrial alterations in Alzheimer's disease.

Baloyannis SJ.

J Alzheimers Dis. 2006 Jul;9(2):119-26. Review.

PMID:
16873959
10.

Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise.

Blass JP, Sheu RK, Gibson GE.

Ann N Y Acad Sci. 2000 Apr;903:204-21. Review.

PMID:
10818509
11.

The role of the metabolic lesion in Alzheimer's disease.

Blass JP, Gibson GE, Hoyer S.

J Alzheimers Dis. 2002 Jun;4(3):225-32. Review.

PMID:
12226541
12.
13.

Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.

Wang X, Su B, Perry G, Smith MA, Zhu X.

Free Radic Biol Med. 2007 Dec 15;43(12):1569-73. Epub 2007 Sep 21. Review.

PMID:
18037122
14.

Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease.

de la Torre JC.

Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S72-81. Review.

PMID:
10850734
15.

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

Sas K, Robotka H, Toldi J, Vécsei L.

J Neurol Sci. 2007 Jun 15;257(1-2):221-39. Epub 2007 Apr 25. Review.

PMID:
17462670
16.

Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease.

Palacios HH, Yendluri BB, Parvathaneni K, Shadlinski VB, Obrenovich ME, Leszek J, Gokhman D, Gąsiorowski K, Bragin V, Aliev G.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):149-62. Review.

PMID:
21222631
17.

Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.

Atamna H, Frey WH 2nd.

Mitochondrion. 2007 Sep;7(5):297-310. Epub 2007 Jun 13. Review.

PMID:
17625988
18.
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk